Benin vs Bhutan: Statin use vs. average non-HDL cholesterol levels
Benin
3
in 2018
Bhutan
3
in 2018
Benin rank
146th
Bhutan rank
146th
Statin use vs. average non-HDL cholesterol levels over time
- Benin
- Bhutan
How they compare
Benin currently reports 3 against 3 in Bhutan, a difference of 0.
Across all 39 years both countries report, Bhutan has been ahead every year.
Benin ranks 146th and Bhutan ranks 146th of 191 countries.
Bhutan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Benin | Bhutan | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.57 | 2.9 | 0.33 | Bhutan |
| 1990s | 2.6 | 3.11 | 0.51 | Bhutan |
| 2000s | 2.71 | 3.2 | 0.49 | Bhutan |
| 2010s | 2.87 | 3.11 | 0.2444 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Benin or Bhutan?
- Benin, at 3 against 3 in Bhutan as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Benin and Bhutan?
- 0, with Benin ahead.
- How many years of comparable data are there for Benin and Bhutan?
- 39 years are reported by both, from 1980 to 2018.
- How do Benin and Bhutan rank globally for statin use vs. average non-hdl cholesterol levels?
- Benin ranks 146th and Bhutan ranks 146th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.